Close
Nordic 9Nordic 9

Aescap Ventures (investor - Private Equity)

Netherlands aescap.com
See something wrong or missing? Let us know
Offices:Amsterdam

Aescap Venture is an Amsterdam-based investment company that pursues investments in biotech companies in Europe and the U.S.

Average round investment:22M USD
Average number per year:1.0
Distribution: 2015 (1)2011 (1)
Portfolio companies: Denmark Orphazyme
Mostly invests in: Denmark Denmark (2) Biotech (2)

2 tracked investments in:

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Investors with similar profile to Aescap Ventures

Name Criteria
United States FMC Ventures
52%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
United States Data Collective (DCVC)
52%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
Switzerland Roche Venture Fund
52%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
Switzerland North East Health Care
52%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
France Lauxera Capital Partners
52%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.0
Finland Fortum
51%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.4
Netherlands LSP (Life Sciences Partners)
51%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.4
Denmark MK Ventures
51%
  • Range for average deal size: 10M - 20M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.5
Denmark Lundbeckfond Ventures
51%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.6
Denmark Sunstone Life Science Ventures
51%
  • Range for average deal size: 20M - 50M USD
  • Similar verticals: Biotech
  • Similar business models: B2B
  • Common investees countries: Denmark
  • Average number of deals per year: 1.6
Top